Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Genexol-PM Once a Week for Gynecologic Cancer [Phase 1]

View source ↗

Summary

Clinical trial update on a Phase 1 study evaluating Genexol-PM for gynecologic cancer; no results disclosed and status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Drugs mentioned

• Genexol-PM (paclitaxel)

Snippet

Sponsor: Samyang Biopharmaceuticals Corporation | Conditions: Gynecologic Cancer | Phase 1 | Status: UNKNOWN